The ESC guidelines on cardio-oncology: incorporating the guidelines into clinical practice

Alexander Lyon, MA, BM BCh, PhD, FRCP, FHFA, Royal Brompton Hospital, London, UK, provides a comprehensive overview of the European Society of Cardiology (ESC) guidelines on cardio-oncology, highlighting how hematologists can incorporate the guidelines into clinical practice. The guidelines provide guidance and tools for all stages of the patient journey to optimize cardiovascular (CV) health and identify potential complications early. A baseline risk assessment allows for the risk stratification of patients and subsequent personalization of the approach to managing cardiac risk. During treatment, drug-drug interactions between cardiology and oncology drugs must be considered. Upon completion of therapy, hematologists should once again risk-stratify patients to identify those needing long-term surveillance for cardiac complications. Dr Lyon encourages clinicians to download the ESC Pocket Guidelines app, which contains an in-depth summary of the guidelines and the necessary risk calculators. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.